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ABSTRACT
Tuberculosis (TB) is further aggravated if it is accompanied with fungal co-infection. This study aimed to evaluate the 
prevalence of pulmonary fungal co-infection among Iranian patients with pulmonary TB using a systematic review 
and meta-analysis. The present study was a review of cross-sectional studies on the prevalence of pulmonary fungal 
co-colonization among Iranian patients with pulmonary TB with regard to the PRISMA Protocol. To this end, the articles 
published online in English and  Persian were searched on the main databases and gateways such as Google Scholar, 
Science Direct, Web of Science, MEDLINE, PubMed, SCOPUS, Cochrane Library, Magiran, Irandoc, and Scientific 
Information Databases. The reviews of the literatures published online from 2000 to the end of 2018 were included in 
the study. The keywords used for searching through the databases were pulmonary fungal co-infection with pulmonary 
TB, pulmonary mycosis co-infection with pulmonary TB, pulmonary fungal colonization/agents with pulmonary TB, 
AND Iran. Finally, the collected data were analyzed by Comprehensive Meta-Analysis software. The analyses showed 
that the prevalence of fungal co-infection among patients with pulmonary TB varied from 12.3-68.8%, and that the 
combined prevalence of fungal co-infection among patients with pulmonary TB was 17.4%. Amongst the fungi involved 
in co-infection with TB, Candida spp. was the most predominant with the prevalence of 6.9%, followed by Aspergillus 
spp. (3.2%). Moreover, the highest prevalence of Aspergillus spp. was observed for Aspergillus fumigatus (1.6%). 
The most frequent Candida spp. was Candida albicans with a frequency of 6%. The findings showed that the combined 
prevalence of fungal co-infection among Iranian patients with pulmonary TB was high. In this regard, among the fungi 
involved in co-infection with TB, Candida spp. was the most frequent.
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ABSTRAK
Batuk kering (TB) menjadi bertambah teruk jika ia diiringi dengan jangkitan bersama kulat. Kajian ini bertujuan untuk 
menilai kelaziman jangkitan bersama kulat dalam kalangan pesakit Iran dengan TB pulmonari menggunakan ulasan 
sistematik dan metaanalisis. Kajian semasa ini adalah penyemakan semula kajian keratan lintang mengenai kelaziman 
pengkolonian bersama kulat dalam kalangan pesakit Iran dengan TB pulmonari berkaitan dengan protokol PRISMA. 
Sehingga kini, kertas yang diterbitkan secara atas talian dalam Bahasa Inggeris dan Parsi telah dicari di pangkalan 
data utama dan get laluan seperti Google Scholar, Science Direct, Web of Science, MEDLINE, PubMed, SCOPUS, Cochrane 
Library, Magiran, Irandoc serta Pangkalan Data Maklumat Saintifik. Ulasan daripada kajian kepustakawan yang 
diterbitkan secara atas talian dari tahun 2000 hingga akhir 2018 telah dimasukkan dalam kajian. Kata kunci yang 
digunakan untuk mencari melalui pangkalan data adalah jangkitan bersama kulat pulmonari dengan TB pulmonari, 
jangkitan bersama mikosis pulmonari dengan TB pulmonari, pengkolonian/agen kulat pulmonari dengan TB pulmonari 
DAN Iran. Akhirnya, data yang diperoleh dianalisis menggunakan perisian metaanalisis yang komprehensif. Analisis ini 
menunjukkan bahawa kelaziman jangkitan bersama kulat dalam kalangan pesakit dengan TB pulmonari berjulat antara 
12.3-68.8% dan gabungan kelaziman untuk jangkitan bersama kulat dalam kalangan pesakit dengan TB pulmonari 
adalah 17.4%. Antara kulat yang terlibat dalam jangkitan bersama TB ialah Candida spp. - paling pradominan dengan 
kelaziman 6.9%, diikuti oleh Aspergillus spp. (3.2%). Selain itu, kelaziman tertinggi Aspergillus spp. telah diperhatikan 
pada Aspergillus fumigatus (1.6%). Candida spp. yang paling kerap ditemui adalah Candida albicans dengan kekerapan 
6%. Hasil kajian menunjukkan bahawa kelaziman jangkitan bersama kulat dalam kalangan pesakit Iran dengan TB 
pulmonari adalah tinggi. Dalam hal ini, antara kulat yang terlibat dalam jangkitan bersama TB, Candida spp. adalah 
yang paling kerap. 
Kata kunci: Aspergillus spp.; batuk kering pulmonari; Candida spp.; jangkitan bersama
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INTRODUCTION
Mycobacterium is a genus of Actinobacteria, which 
induce a variety of diseases in human beings. Moreover, 
tuberculosis (TB) complex species also cause serious 
diseases in human, including TB (Mycobacterium TB) 
and leprosy (Mycobacterium leprae). Nontuberculous 
mycobacteria play a critical role in medical microbiology 
(Khaledi et al. 2017, 2016). In general, nontuberculous 
mycobacteria are nonpathogenic microorganisms; 
however, they sometimes induce infection in individuals 
with immune-compromised conditions (Akbari et al. 
2015).
 TB is a chronic disease with pulmonary and extra-
pulmonary forms (Amiri et al. 2018a). More than 85% of 
TB cases are pulmonary, and some are extra-pulmonary. TB 
infects one-third of the world population, and about two 
million people died annually from TB (Ashna et al. 2018). 
More than 95% of pulmonary forms of TB are reported 
in developing countries such as the Middle East, Latin 
America, Africa, and Asia (Amiri et al. 2018b).
 To the best of our knowledge, the problem with the 
pulmonary form is infection with opportunistic fungi that 
do not cause infection in normal conditions; however, 
they can be problematic if susceptible hosts are present, 
making pulmonary more severe and posing difficulties 
in the treatment of TB (Richardson & Lass-Flörl 2008). 
Opportunistic fungal infections are typically formed 
by non-pathogenic fungal agents in patients whose 
immune responses are damaged by various predisposing 
factors (Romani 2011). A large increase in the number 
of immunocompromised hosts leads to an increase in 
opportunistic fungal infections and subsequently enhances 
the morbidity and mortality rates (Garber 2001). 
 One of the main opportunist fungi is Candida spp., 
particularly C. albicans with the prevalence rate of 10-90%. 
Many studies have reported the prevalence of pulmonary 
TB co-infection with Candidiasis to be about 15-35% 
(Naz & Tariq 2004). The chronic nature of TB is further 
aggravated if it is accompanied with fungal co-infection. 
In this case, it remains undetectable and consequently 
untreated (Denning et al. 2011). 
 The co-occurrence of Candida species and TB has 
been documented long time ago (Longo et al. 1958). When 
accompanied with primary diseases such as TB, Candida 
infections may cause many complications in patients, 
especially in those with predisposing factors for fungal 
infections such as weak immune status and damaged 
lung tissues and TB-induced lesions (Rathod et al. 2012). 
Additionally, prolonged treatment with antibiotics and 
corticosteroids further expose these patients to fungal 
opportunistic infections.
 Individuals sometimes suffer from pulmonary TB 
treated by antibiotics, which have complications such 
as progressive injury of lungs, persistent pulmonary 
symptoms, and chronic pulmonary mycosis (Denning 
et al. 2011b). Chronic pulmonary mycosis, in particular 
contamination with aspergillosis, is a remarkable 
differential diagnosis in patients with smear-negative 
TB. Amongst different Aspergillus spp., A. fumigatus 
is the most frequent (Kosmidis & Denning 2015). The 
most important form of Aspergillus is chronic pulmonary 
aspergillosis (CPA) with or without aspergilloma (Denning 
2009). In comparison to invasive aspergillosis, however, 
CPA occurs in individuals with immune deficiency, leading 
to a high mortality rate of about 10-30% (Nam et al. 2010), 
systemic and respiratory symptoms, hemoptysis (Denning 
et al. 2003), weight loss, profound fatigue, and decreased 
lung function (Camuset et al. 2007).
 Considering the critical role of fungal agents and 
their co-infection with TB and given that there is no 
comprehensive review in this regard, a systematic 
review and meta-analysis was carried out in the present 
study to determine the prevalence of pulmonary fungal 
co-infection among Iranian patients with pulmonary TB 
through summarizing the data collected from the published 
literature. We followed the MOOSE (Meta-Analyses 
and Systematic Reviews of Observational Studies) and 
the Preferred Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines to report the findings from 
this systematic review and meta-analysis (Stroup et al. 
2000).
MATERIALS AND METHODS
SEARCH STRATEGY
The present study was a review of cross-sectional studies 
on the prevalence of pulmonary fungal co-infection among 
Iranian patients with pulmonary TB in accordance with the 
PRISMA directions (Stroup et al. 2000) (File 1). For this 
purpose, papers published in both national and international 
databases were surveyed. Articles published online in 
English and Persian from 2000 to the end of 2018 were 
selected from international (Google Scholar, PubMed, 
MEDLINE, SCOPUS, Cochrane Library, ScienceDirect, and 
Web of Science) and with similar strategies and related 
Persian keywords through national (SID, Magiran, and 
Irandoc) databases and gateways. Additionally, the reference 
lists of the articles were also checked for further studies. 
 The keywords used for searching the databases 
were pulmonary fungal co-infection with pulmonary 
tuberculosis, pulmonary mycosis co-infection with 
pulmonary tuberculosis, pulmonary fungal infections/
agents with pulmonary tuberculosis, AND Iran. 
INCLUSION AND EXCLUSION CRITERIA
In this study, inclusion criteria were as follows: 
Observational studies reporting the prevalence of 
pulmonary fungal co-infection with pulmonary TB; cross-
sectional, full-text papers published from 2000 to the end 
of 2018 with relevant subject. On the other hand, those 
studies not addressing the research topic, getting published 
before 2000, commentaries, abstracts, case series, case 
reports, meeting reports, letters to editor, congress articles, 
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editorials, literatures containing incoherent data reporting, 
articles reported in languages other than English or Persian, 
republished papers, literature reviews, meta-analysis, 
systematic and narrative reviews were excluded.
SCREENING
All the studies found in the aforementioned databases were 
entered into our prepared database in order for the copied 
papers to be eliminated. Then,  the articles were screened 
by two reviewers (AM & SM) at three levels (namely, 
title and abstract screening, topic screening, and full-text 
screening). At each level, the reviewers independently 
screened the papers, and their findings were merged upon 
their agreements. The inconsistencies were resolved by 
debate before finalizing the studies for the next screening 
step. The disagreements between the reviewers were 
discussed and resolved by agreement; however, when no 
agreement was reached, a third reviewer made the final 
decision. Finally, the articles were assessed in terms of 
eligibility for final selection.
QUALITY OF STUDIES
The quality of the methods in the concerned studies was 
assessed using the criteria declared in Critical Appraisal 
Skills Programmed checklists (www.casp-UK). A set of 
key questions were considered for each study. If relevant 
information was explicitly stated, the relevant question 
would be answered as ‘Yes’. If there was any kind of 
doubt or the information was not explicitly described in the 
paper, the question would be responded as ‘No’ or ‘Can’t 
tell’. The overall rating of the studies ranged from ‘strong’ 
and ‘intermediate’ to ‘weak’ according to the number of 
questions marked as ‘Yes’(CASP 2006). At the end, the 
studies of low quality were removed from the present study.
ASSESSING THE RISK OF BIAS
In the concerned articles, the study design, methods, 
context, results, data analyses, and interpretations were 
examined for quality evaluation. Incoherent reviews of 
literature were excluded from the present investigation. 
Furthermore, the disagreements on the quality evaluation 
were resolved by debates between the two raters or the 
third reviewer (Auguste et al. 2017).
DATA EXTRACTION
The two reviewers independently extracted the necessary 
data from the selected articles. The concerned information 
encompassed first author, year of study, year of publication, 
sample size, genus, age, location, co-infection, and fungi 
species. The disagreement between the reviewers was 
resolved through discussion.
STATISTICAL ANALYSIS
The analysis was performed by Comprehensive Meta-
Analysis Software Version 2.0 (Biostat, Englewood, 
NJ). The prevalence rate was reported at 95% confidence 
intervals (CIs). 
RESULTS
STUDY SELECTION
As shown in Figure 1, 162 records were detected from 
a systematic literature search of different electronic 
databases and gateways, of which 51 copied records were 
removed, and 111 records were screened. Out of these 
111 articles, 61 papers were excluded because of their 
irrelevant topics, titles, and review articles, and 50 full-text 
articles were further evaluated for eligibility. Regarding 
the eligibility criterion, 46 papers were excluded after a 
full text assessment (25 articles for lack of required data 
and 21 articles for not describing the prevalence rates). 
Finally, the studies (n = 4) were included in the quantitative 
synthesis (meta-analysis). 
FEATURES OF THE SELECTED STUDIES
As presented in Table 1, the patients with positive 
pulmonary TB were 700 persons. The age of the patients 
ranged from 10 to 91 years (with the mean age of 48 years). 
FIGURE 1. This Flow diagram shows the selection                
process of included studies
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The type of clinical samples in most cases was sputum 
followed by Bronchoalveolar lavage (BAL) and serum. 
FINDINGS OF THE COMBINED PREVALENCE
According to the findings listed in Table 2 and Figure 2, 
the prevalence of fungal co-infection among patients with 
pulmonary TB varied from 12.3% to 68.8%. Table 2 and 
Figure 3 show that the combined prevalence of fungal 
co-infection among Iranian patients with pulmonary TB 
was 17.4% (95% CI: 7.3-36.1, Q=3 and Z=3.09). Table 
3 indicates that, amongst fungi involved in co-infection 
with TB, Candida spp. was the most predominant with 
the prevalence rate of 6.9% (95% CI: 5.3-9, P=0.00, t=0.4, 
Z=17.6), followed by Aspergillus spp. with the prevalence 
rate of 3.2% (95% CI: 2.4-4.2, P=0.00, t=0.5, Z=23.2). 
The most frequent Candida spp. was C. albicans with 
the frequency of 6% (95% CI: 4.4-8.3). Moreover, the 
most frequent Aspergillus spp. was A. fumigatus with the 
prevalence rate of 1.6% (95% CI: 1.1-2.3). Other features 
of Candida and Aspergillus spp. are shown in Table 3. 
 The publication bias was checked using Funnel plot, 
and the results (Figure 3) showed no publication bias for 
the combined prevalence of co-infection and Candida spp.; 
however, publication bias was reported for the prevalence 
of Aspergillus spp. Considering possible asymmetrical 
data distribution in the selected studies, the Egger’s linear 
regression was used to further examine the publication bias; 
however, the results of the Egger’s linear regression also 
showed no publication bias (P = 0.6) (Table 1). 
 In all the studies, bacterial staining such as Ziehl–
Neelsen and fluorochrome and mycological examination 
(10% KOH+ Calcofluor White staining by fluorescent 
microscopy and fungal culture on Sabouraud dextrose agar, 
Czapek, and CHROMagar) were used for the detection and 
identification of infectious agents. 
DISCUSSION
In the present review, the prevalence of fungal co-infection 
among Iranian patients with pulmonary TB varied from 
12.3% to 68.8%. The combined prevalence of fungal 
co-infection was 17.4% among Iranian TB patients. Our 
findings are in line with those of Baradkar et al. (2009), 
Khanna et al. (1977), and Naz and Tariq (2004), as they 
reported the high prevalence of fungal co-infection with 
TB; however, the results of the study by Latha et al. (2011) 
reported a lower prevalence rate. The inconsistency might 
be caused by variations in the geographical dissemination, 
genetic features of patients, occupation of patients, sample 
size, duration of anti-TB consumption by patients, and 
methods used for detection (Astekar et al. 2016).
 According to the results derived from the present 
study regarding the fungi involved in co-infection with TB, 
Candida spp. was the most frequent with the prevalence 
rate of 6.9%. Moreover, the most leading Candida spp. 
was C. albicans with the frequency of 6%. The results 
of this study are in line with the findings of the studies 
conducted by Kali et al. (2013) and Phukan et al. (2000). 
Similarly, they reported C. albicans as the most common 
fungus associated with infections in patients with immune-
compromised conditions such as TB. In addition, a study 
carried out by Naz and Tariq (2004) in Pakistan showed 
15.2% co-infection of tuberculous patients admitted in 
hospital with Candida spp. In a similar study conducted 
in China showed 21.6% of fungal co-occurrence with 
Candida spp. among hospitalized patients with underlying 
primary pulmonary diseases (Liu et al. 2003). 
 C. albicans is present in hospital environments, 
air, inanimate surfaces, and even food substances. It 
is considered as the common yeast recovered from 
tuberculous patients and is responsible for producing 
severe secondary infections in these patients (Fontalvo 
et al. 2016). Nevertheless, the current findings are in 
contrast with those of Naz and Tariq (2004) who indicated 
C. tropicalis as the frequent species. The reason for this 
difference is likely to be the inclusion of AIDS positive 
patients in their study, where C. tropicalis more strongly 
attacked deep tissues of immunocompromised individuals 
compared to C. albicans (Meurman et al. 2007). 
 Many researchers have identified different Candida 
spp. as the most common fungal agents isolated from 
patients’ mucus production with pulmonary TB (Kali 
et al. 2013). The reason is that the correlation between 
synergistic growth-promoting and M. TB has also been 
empirically documented (Latha et al. 2011). 
 However, due to the fact that Candida spp. is 
present in the normal flora of 15-30% of individuals, the 
importance of infections caused by it is controversial and 
may contaminate sputum samples when sampling (El-
Ebiary et al. 1997). It should be noted that patients with 
TB have a deficiency in the function of immunological 
cells including monocytes, macrophages, and T cells, 
as well as chemotaxis that can predispose patients to 
opportunistic fungal infections (Dagenais & Keller 2009). 
Due to the development of cavities after the healing of TB, 
aspergillosis can be placed in cavities after a long time 
and form aspergilloma (Smith & Denning 2011). Among 
various underlying conditions, TB is the most important 
factor in the development of CPA (Ohba et al. 2012).
 In the present study, the combined prevalence of 
Aspergillus spp. was 3.2%. Among them, the highest 
prevalence of Aspergillus spp. was associated with A. 
fumigatus (1.6%). Based on reports, A. fumigatus is the 
most frequent species involved in all pulmonary disorders 
(Kosmidis & Denning 2015). In contrast to our study, in 
studies conducted by Ekkena et al. (2007), Kurhade et al. 
(2002), Njunda et al. (2012), and Osman et al. (2013), 
Aspergillus spp. was detected in 24%, 15%, 16.26% and 
42.9% of cases, respectively. The observed difference 
between these studies with the current study may be due to 
the number of reviewed studies and diverse geographical 
distribution (Osman et al. 2013).
 Our findings are in accordance with results obtained 
by Kurhade et al. (2002) and Shahid et al. (2001) who 
described A. fumigatus as the predominant species in 
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FIGURE 2. This figure shows the Forest plot of the meta-analysis of the prevalence of pulmonary 
fungal Coinfection among Iranian patients with pulmonary tuberculosis
FIGURE 3. This shows the publication bias of the meta-analysis on the prevalence of pulmonary fungal 
Coinfection among Iranian patients with pulmonary tuberculosis
TABLE 3. Sub-groups analysis of Candida and Aspergillus species in this study
Candida species
Overall effects Number of studies
Heterogeneity test Egger’s test Random model
Prevalence
(95% CI) (%) Z P Q P I
2 T  P
Candida albicans
Candida krusei
Candida glabrata
Candida tropicalis
Candida pseudotropicalis
Non-Candida spp
3
2
1
1
1
1
6%(4.4-8.3)
0.7%(0.3-1.8)
1%(0.3-3.9)
1%(0.3-3.9)
1%(0.3-3.9)
0.1%(0-0.03)
15.6
9.9
6.4
6.4
6.4
13.5
0.00
0.00
1
1
1
0.00
72.7
0.59
0.00
0.00
0.00
0.00
0.07
0.00
0.00
0.00
0.00
0.00
97.2
0.00
0.00
0.00
0.00
0.00
1
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Aspergillus species
Aspergillus flavus
Aspergillus fumigatus
Aspergillus niger
Aspergillus oryzae
3
4
3
1
0.8%(0.4-1.4)
1.6%(1.1-2.3)
0.1%(0.1-0.8)
0.2%(0-1.6)
15.8
20.6
12.6
6
0.00
0.00
0.01
1.00
17.9
58
7.9
0.00
0.48
0.6
0.5
0.00
88.8
94.8
74.8
0.00
1.05
0.4
0.9
0.00
0.00
0.00
0.00
0.00
pulmonary TB. In contrast with our review, some studies 
(Biswas et al. 2010; Sivasankari et al. 2014) showed A. 
flavus and A. niger as the most common species in the 
Aspergillus genus. Moreover, in the present study, A. flavus 
and A. niger were reported to be low with the prevalence 
of 0.8% and 0.1%, respectively. In contrary to our findings, 
the frequency of A. flavus in the study conducted by Shahid 
and Malik (2002) was obtained as high as 30%. The 
increased prevalence of opportunistic fungal colonization 
is attributed to the weakness of the immune system in TB 
patients and the use of anti-TB drugs which provoke the 
growth of the fungus flora and thus aggravate the course 
of underlying diseases in the lung tissues (Naz & Tariq 
2004).
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 In regions with a high occurrence of TB, criteria 
for identifying both CPA and TB are highly identical, 
which make it impossible to distinct between the two 
microorganisms without serological tests for Aspergillus 
antigens, even if the culture of samples (sputum) is 
positive for A. fumigatus (Denning et al. 2011).
 Despite that the patients completed the course 
of treatment for TB; secondary fungal infections had 
persistence of pulmonary symptoms. Therefore, suitable 
measures should be taken for patients in endemic areas 
for the potential of co-infection so that it can be identified 
and treated promptly (Mathavi et al. 2014). 
 Furthermore, all fungi detected in clinical specimens 
from patients, especially immune-compromised patients 
and those suffering from pulmonary TB, should be 
carefully examined and evaluated by physicians regarding 
their clinical significance (Chadeganipour et al. 2000).
 Due to the importance of TB, attention should be paid 
more to the co-infection of TB with opportunistic fungi. 
In addition, because of comparable clinical signs of TB 
and pulmonary fungal co-infection, for cases in which 
the direct smear and culture of samples are negative for 
TB, specimens must be evaluated for opportunistic fungi. 
 This review has several strengths. Accordingly, we 
performed a comprehensive study through searching 
in several databases based on the available standard 
protocol. To this end, we used two independent reviewers 
who searched for relevant studies and resolved any 
disagreements via discussion. Moreover, we used 
subgroups analysis for heterogeneity reduction. 
 However, the present study has also some limitations. 
First of all, we did not have access to all studies conducted 
in this field, related unpublished works, and literatures 
reported in languages other than English or Persian. 
Furthermore, we completed meta-analysis only on data 
obtainable in databases and gateways and did not contact 
the authors of the selected studies to achieve more 
information when further clarification required. Finally, 
we conducted this review with only four selected studies. 
CONCLUSION
In general, based on our results, the combined prevalence 
of fungal co-infection is high among Iranian patients with 
pulmonary TB. Moreover, our results showed Candida 
spp. to be the most prevalent among fungi complicated in 
co-infection with TB. It is suggested to further investigate 
factors affecting fungal co-infection with pulmonary TB 
as well as complications resulting from the misdiagnosis 
of co-infection.
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